Orient Pharmaceutical Company Limited

--Going into the medicine and healthcare products market through new and high productivity technologies

Orient Pharmaceutical Company Limited is a joint venture between the Kingold Group and Southern Medical University with a registered capital of 80 million yuan and total investment in excess of 100 million yuan.

The company is committed to the promotion of traditional Chinese medicines and therapies, the protection of people’s health and improvement of life quality. By following the belief of the Kingold Group to do the best and making full use of R&D capabilities of Southern Medical University, the company is engaged in the development and production of high-quality traditional Chinese medicine products and healthcare products, following a philosophy of driving business with technological innovations by combining production with study and research.

Orient Pharmaceutical Company Limited has a total floor space of 16,163 square meters with 9000 square meters of workshop space, a production base for medicine, healthcare products and cosmetics built in compliance with GMP standards. The oral liquid preparation workshop, solid preparation workshop and cosmetics workshop are equipped with automatic production lines of oral liquid, boiling desiccating granulators, automatic capsule filling machines, turbo rotating tabletting machines and automatic aluminum plastic packers with an annual production capacity of 100 million bottles of oral liquid, 200 million tablets, 200 million capsules, 50 million packets of granules, 50 million packets of pills and 100 million units of cosmetics.

Following the standards for a state-level R&D center, Orient Pharmaceutical Company Limited has set up R&D facilities for drugs and healthcare products, traditional Chinese medicine, for drug addiction treatment, and healthcare products for women in collaboration with Southern Medical University. It is planned that in a period of three years ,60 million yuan will be invested into research on new drugs, healthcare products and other health-related products. In addition to traditional pharmaceutical market, Orient Pharmaceutical Company Limited is also moving into direct selling business relying on its corporate credibility and research strength. It is aiming to build a first class Chinese brand name in direct selling business with its quality products, compliance with the laws and regulations, and corporate governance under a direct selling license.